Recent studies have identified the activation of adhesion molecules, including Lutheran/basal cell adhesion molecule (Lu/BCAM) and CD44, on uRBCs from both in vitro Plasmodium falciparum cultures and malaria patients [70]. This evidence concerns the gene BCAM and malaria.